Holen Sie sich die Stockscreener-App
2.22
18.09%
0.34
Schlusskurs vom Vortag:
$1.88
Offen:
$1.85
24-Stunden-Volumen:
21.15M
Relative Volume:
2.66
Marktkapitalisierung:
$670.23M
Einnahmen:
$188.87M
Nettoeinkommen (Verlust:
$-400.38M
KGV:
-1.48
EPS:
-1.5
Netto-Cashflow:
$-260.90M
1W Leistung:
+37.89%
1M Leistung:
+16.84%
6M Leistung:
+126.25%
1J Leistung:
+25.42%
1-Tages-Spanne:
$1.8317
$2.235
1-Wochen-Bereich:
$1.5235
$2.235
52-Wochen-Spanne:
$0.8511
$2.46
Pacific Biosciences Of California Inc Stock (PACB) Company Profile
Firmenname
Pacific Biosciences Of California Inc
Sektor
Branche
Telefon
650-521-8000
Adresse
1305 O'BRIEN DRIVE, MENLO PARK, CA
Vergleichen Sie PACB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PACB
Pacific Biosciences Of California Inc
|
2.22 | 567.59M | 188.87M | -400.38M | -260.90M | -1.50 |
|
ABT
Abbott Laboratories
|
128.11 | 215.57B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.88 | 143.20B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
368.27 | 137.86B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.20 | 127.43B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 48.80B | 5.88B | 1.34B | 799.60M | 2.3489 |
Pacific Biosciences Of California Inc Stock (PACB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-11 | Herabstufung | UBS | Buy → Neutral |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-22 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-04-18 | Herabstufung | Goldman | Buy → Neutral |
| 2023-12-14 | Eingeleitet | Guggenheim | Neutral |
| 2023-12-14 | Eingeleitet | Stephens | Overweight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-11-17 | Hochstufung | UBS | Neutral → Buy |
| 2023-10-31 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-06-30 | Eingeleitet | Goldman | Buy |
| 2023-05-10 | Eingeleitet | Barclays | Equal Weight |
| 2023-03-31 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-02-02 | Eingeleitet | UBS | Neutral |
| 2023-01-20 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-01-21 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-09-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-02-11 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2020-11-03 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-10-02 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-06-02 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-03-09 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2019-10-15 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2019-04-02 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2018-10-19 | Eingeleitet | Cowen | Outperform |
| 2017-11-03 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2017-09-28 | Herabstufung | CL King | Buy → Neutral |
| 2016-11-03 | Bestätigt | Cantor Fitzgerald | Buy |
| 2016-06-27 | Eingeleitet | CL King | Buy |
| 2016-04-15 | Eingeleitet | First Analysis Sec | Overweight |
| 2016-02-04 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2016-01-04 | Bestätigt | Cantor Fitzgerald | Buy |
| 2015-10-23 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2015-08-27 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2015-02-04 | Bestätigt | Maxim Group | Buy |
| 2013-09-26 | Bestätigt | Maxim Group | Buy |
| 2013-01-14 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Pacific Biosciences Of California Inc Aktie (PACB) Neueste Nachrichten
What analysts say about Pacific Biosciences of California Inc stock - earlytimes.in
PacBio Stock Soars: Time to Dive In? - StocksToTrade
Pacific Biosciences of California launches HiFi guide to enhance lab workflows - Traders Union
PacBio’s Regulatory Triumph in China Fuels Market Optimism - timothysykes.com
PacBio’s New Regulatory Approval Fuels Expansion Hopes - timothysykes.com
Pacific Biosciences partners with SPT Labtech to enhance automation - Traders Union
Will Pacific Biosciences of California Inc. (P09) stock beat revenue estimates2025 Earnings Impact & Real-Time Volume Analysis Alerts - newser.com
How higher bond yields impact Pacific Biosciences of California Inc. (P09) stockCEO Change & Consistent Profit Trade Alerts - newser.com
Will Pacific Biosciences of California Inc. stock split again soon2025 Growth vs Value & AI Based Buy/Sell Signal Reports - newser.com
Will Pacific Biosciences of California Inc. (P09) stock announce special dividendWeekly Trend Report & Daily Chart Pattern Signals - newser.com
Is Pacific Biosciences of California Inc. stock ready for a breakoutProfit Target & Low Risk High Win Rate Stock Picks - newser.com
Price to cash flow ratio of Pacific Biosciences of California, Inc. – HAM:P09 - TradingView
Will Pacific Biosciences of California Inc. stock recover after recent dropJuly 2025 Gainers & Weekly High Conviction Trade Ideas - newser.com
Does Pacific Biosciences of California Inc. stock trade at a discount to peers - newser.com
Is Pacific Biosciences of California Inc. stock a top pick in earnings seasonMarket Risk Analysis & Weekly High Potential Alerts - newser.com
Why Pacific Biosciences of California Inc. (P09) stock could be next leaderChart Signals & Real-Time Chart Pattern Alerts - newser.com
Smart tools for monitoring Pacific Biosciences of California Inc.’s price actionCEO Change & Entry Point Strategy Guides - newser.com
Is Pacific Biosciences of California Inc. (P09) stock attractive for dividend growth2025 Big Picture & Long-Term Growth Stock Strategies - newser.com
Is Pacific Biosciences of California Inc. (P09) stock at risk of policy regulationPortfolio Growth Summary & Weekly Chart Analysis and Trade Guides - newser.com
Pacific Biosciences of California: Radboud University unveils HiFi sequencing for genetic tests - Traders Union
Price action breakdown for Pacific Biosciences of California Inc.July 2025 Recap & Fast Entry Momentum Alerts - newser.com
Pacific Biosciences of California appoints CFO - MSN
Will Pacific Biosciences of California Inc. continue its uptrendWeekly Stock Recap & AI Powered Trade Plan Recommendations - newser.com
How to build a custom watchlist for Pacific Biosciences of California Inc.Market Risk Report & AI Powered Market Trend Analysis - newser.com
Can Pacific Biosciences of California Inc. stock resist market sell offs2025 EndofYear Setup & Community Consensus Trade Alerts - newser.com
Finanzdaten der Pacific Biosciences Of California Inc-Aktie (PACB)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):